Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
7 Biotech Stocks With Catalysts That Go Far Beyond Covid-19 Vaccines
11:54am, Friday, 12'th Mar 2021
If you think ecommerce and digital banking have accelerated in the past year, then you really need to check out promising biotech stocks. The post 7 Biotech Stocks With Catalysts That Go Far Beyond Co
Seagen Recommends Rejection Of 'Mini-Tender' Offer from TRC Capital Investment Corporation
08:00am, Friday, 05'th Mar 2021
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced that it has been notified of an unsolicited “mini-tender” offer dated February 22, 2021, made by TRC Capital Investment C
Seagen (SGEN), Astellas Submit 2 sBLAs to FDA for Urothelial Cancer
12:07pm, Friday, 19'th Feb 2021
Seagen (SGEN) and Astellas Pharma announced completion of submissions of two sBLAs to the FDA for Padcev in patients with locally advanced or metastatic urothelial carcinoma.
BOTHELL, Wash. & TOKYO--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced completion of submissi
BOTHELL, Wash. & TOKYO--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced results from the secon
Seagen (SGEN) Q4 Earnings Beat Estimates, Revenues Rise Y/Y
11:22am, Friday, 12'th Feb 2021
Seagen (SGEN) surpasses estimates for earnings and revenues in the fourth quarter of 2020. The company provides revenues guidance for 2021.
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced that the European Commission (EC) has granted marketing authorization for TUKYSA® (tucatinib) in combination with trastuzuma
Seagen' (SGEN) CEO Clay Siegall on Q4 2020 Results - Earnings Call Transcript
10:54pm, Thursday, 11'th Feb 2021
Seagen' (SGEN) CEO Clay Siegall on Q4 2020 Results - Earnings Call Transcript
Seattle Genetics (SGEN) Q4 Earnings and Revenues Top Estimates
06:56pm, Thursday, 11'th Feb 2021
Seattle Genetics (SGEN) delivered earnings and revenue surprises of 11.11% and 3.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Seagen (SGEN) Submits BLA to FDA for Cervical Cancer Drug
12:06pm, Thursday, 11'th Feb 2021
Seagen (SGEN) submits a BLA to the FDA for accelerated approval of tisotumab vedotin in patients with recurrent/metastatic cervical cancer, whose disease has progressed on or after chemotherapy.
Why Earnings Season Could Be Great for Seagen (SGEN)
09:25am, Wednesday, 10'th Feb 2021
Seagen (SGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's Why Seagen Jumped Higher Today
05:50pm, Friday, 05'th Feb 2021
The rumor mill took hold in late-day trading.
BMEZ: Healthcare Exposure With A ~4% Yield And Growth Potential
04:05am, Saturday, 30'th Jan 2021
BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and private i
American BriVision: Deep Dive Into Market Potential
03:38pm, Thursday, 14'th Jan 2021
American BriVision: Deep Dive Into Market Potential
The Top 3 Biotech Stocks to Buy in 2021
07:05am, Sunday, 10'th Jan 2021
Revenue growth is just beginning for these companies.
